AU Patent

AU2007208169A1 — Use of gallium to treat biofilm-associated infectons

Assigned to Titan Pharmaceuticals Inc · Expires 2007-08-02 · 19y expired

What this patent protects

Patent listed against Sandimmune.

Drugs covered by this patent

Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)

Patent Metadata

Patent number: AU2007208169A1
Jurisdiction: AU
Classification: —
Expires: 2007-08-02
Drug substance claim: No
Drug product claim: No
Assignee: Titan Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.